In research published in Science Advances, scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for Huntington’s disease, an incurable, debilitating illness that causes nerve cells to break down in the brain.
By applying a sophisticated machine-learning approach to electronic health records of patients with pneumonia, investigators at Northwestern University have uncovered five distinct clinical states in pneumonia.
Within a few days of injury, scientists can predict which patients will develop chronic pain based on the extent of cross “talk” between two regions of the brain, and the person’s anxiety level after the injury, according to a new Northwestern study.
A team of scientists led by Northwestern Medicine investigators has created an implant capable of stopping an opioid overdose, according to findings published in Science Advances.
The number of pediatric inpatient psychiatric beds has not risen to meet demand amid a growing youth mental health crisis, according to a Northwestern Medicine-led study published in JAMA Pediatrics.
Treatment with endovascular thrombectomy did not significantly improve outcomes after 90 days in patients with a large core stroke, as compared to patients who received standard stroke care alone, according to a recent clinical trial published in JAMA.
Investigators led by Pablo Penaloza-MacMaster, PhD, associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination significantly improved vaccine efficacy in mice, according to findings published in The Journal of Clinical Investigation.
Robert Bonow, MD, the Max and Lilly Goldberg Distinguished Professor of Cardiology and a leading authority on valvular heart disease, has been named a 2024 Distinguished Scientist by the American Heart Association.
Scientists have discovered an RNA that controls how much or how little protein is produced by a gene, with implications for neurodevelopmental disorders like epilepsy and autism.
Targeting a specific neural circuit through noninvasive neuromodulation may reduce symptoms in patients with posttraumatic stress disorder (PTSD), according to a recent study published in Nature Neuroscience.